Topics
14 topics, 80 articles.
Trial readouts
8 articles. Latest: Mazdutide GLORY-1: Approved in One Country Only
Compounds not yet covered
7 articles. Latest: ARA-290: The Innate Repair Receptor and Phase 2 Data
Peptide pharmacokinetics
7 articles. Latest: Gastric-Emptying Tachyphylaxis and Exposure Pattern
Pharmacology
7 articles. Latest: Afamelanotide: MC1R Agonism and Two Phase 3 Trials
GH axis pharmacology
6 articles. Latest: MK-677: An Oral Secretagogue With Two-Year Trial Data
Mechanisms
6 articles. Latest: Selank: Proposed Anxiolytic Mechanism and the State of the Evidence
Structure and modification
6 articles. Latest: Antibody-Peptide Conjugates: A Half-Life by Design
Evidence base
5 articles. Latest: HCG: A Real Hormone Attached to a Refuted Diet Claim
Glp 1 outside metabolic disease
5 articles. Latest: GLP-1 in Parkinson's: LixiPark Positive, Exenatide Null
Immune and mitochondrial peptides
5 articles. Latest: Humanin and the Mitochondrial-Derived Peptide Family
Incretin pipeline pharmacology
5 articles. Latest: Amycretin: One Molecule, Two Receptor Families
Receptor pharmacology fundamentals
5 articles. Latest: Orthosteric or Allosteric: Where a Peptide Ligand Binds and Why It Changes the Pharmacology
Fundamentals
4 articles. Latest: Reading a Peptide Sequence: Direction, Codes, Fragments and Modifications
Safety signals and pharmacovigilance
4 articles. Latest: Signal, Cohort, Trial: Tiers of Drug-Safety Evidence